This report aims to provide a comprehensive presentation of the global market for Autologous Matrix-Induced Chondrogenesis (AMIC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Matrix-Induced Chondrogenesis (AMIC). This report contains market size and forecasts of Autologous Matrix-Induced Chondrogenesis (AMIC) in global, including the following market information:
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Autologous Matrix-Induced Chondrogenesis (AMIC) market was valued at US$ 104.6 million in 2022 and is projected to reach US$ 144 million by 2029, at a CAGR of 4.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hyaluronic Acid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autologous Matrix-Induced Chondrogenesis (AMIC) include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH and Smith & Nephew plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autologous Matrix-Induced Chondrogenesis (AMIC) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment Percentages, by Type, 2022 (%)
Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Polylactic-Co-Glycolic Acid (PGLA)
Others
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment Percentages, by Application, 2022 (%)
Knee Cartilage Repair
Hip Cartilage Repair
Elbow Cartilage Repair
Others
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autologous Matrix-Induced Chondrogenesis (AMIC) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autologous Matrix-Induced Chondrogenesis (AMIC) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anika Therapeutics, Inc.
Arthro-Kinetics
B. Braun Melsungen AG
BioTissue AG
CartiHeal
Geistlich Pharma AG
JRI Orthopaedics Ltd.
Matricel GmbH
Smith & Nephew plc
Zimmer Biomet Holdings
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autologous Matrix-Induced Chondrogenesis (AMIC), market overview.
Chapter 2: Global Autologous Matrix-Induced Chondrogenesis (AMIC) market size in revenue.
Chapter 3: Detailed analysis of Autologous Matrix-Induced Chondrogenesis (AMIC) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autologous Matrix-Induced Chondrogenesis (AMIC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Overall Market Size
2.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size: 2022 VS 2030
2.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players in Global Market
3.2 Top Global Autologous Matrix-Induced Chondrogenesis (AMIC) Companies Ranked by Revenue
3.3 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Companies
3.4 Top 3 and Top 5 Autologous Matrix-Induced Chondrogenesis (AMIC) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Autologous Matrix-Induced Chondrogenesis (AMIC) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autologous Matrix-Induced Chondrogenesis (AMIC) Players in Global Market
3.6.1 List of Global Tier 1 Autologous Matrix-Induced Chondrogenesis (AMIC) Companies
3.6.2 List of Global Tier 2 and Tier 3 Autologous Matrix-Induced Chondrogenesis (AMIC) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size Markets, 2022 & 2030
4.1.2 Hyaluronic Acid
4.1.3 Collagen
4.1.4 Polyethylene Glycol (PEG)
4.1.5 Polylactic-Co-Glycolic Acid (PGLA)
4.1.6 Others
4.2 By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue & Forecasts
4.2.1 By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2023
4.2.2 By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2024-2030
4.2.3 By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2022 & 2030
5.1.2 Knee Cartilage Repair
5.1.3 Hip Cartilage Repair
5.1.4 Elbow Cartilage Repair
5.1.5 Others
5.2 By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue & Forecasts
5.2.1 By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2023
5.2.2 By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2024-2030
5.2.3 By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2022 & 2030
6.2 By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue & Forecasts
6.2.1 By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2023
6.2.2 By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2024-2030
6.2.3 By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2030
6.3.2 US Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.3.3 Canada Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.3.4 Mexico Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2030
6.4.2 Germany Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4.3 France Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4.4 U.K. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4.5 Italy Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4.6 Russia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4.7 Nordic Countries Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.4.8 Benelux Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2030
6.5.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.5.3 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.5.4 South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.5.5 Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.5.6 India Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2030
6.6.2 Brazil Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.6.3 Argentina Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2030
6.7.2 Turkey Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.7.3 Israel Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.7.4 Saudi Arabia Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
6.7.5 UAE Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, 2018-2030
7 Autologous Matrix-Induced Chondrogenesis (AMIC) Companies Profiles
7.1 Anika Therapeutics, Inc.
7.1.1 Anika Therapeutics, Inc. Company Summary
7.1.2 Anika Therapeutics, Inc. Business Overview
7.1.3 Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.1.4 Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.1.5 Anika Therapeutics, Inc. Key News & Latest Developments
7.2 Arthro-Kinetics
7.2.1 Arthro-Kinetics Company Summary
7.2.2 Arthro-Kinetics Business Overview
7.2.3 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.2.4 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.2.5 Arthro-Kinetics Key News & Latest Developments
7.3 B. Braun Melsungen AG
7.3.1 B. Braun Melsungen AG Company Summary
7.3.2 B. Braun Melsungen AG Business Overview
7.3.3 B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.3.4 B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.3.5 B. Braun Melsungen AG Key News & Latest Developments
7.4 BioTissue AG
7.4.1 BioTissue AG Company Summary
7.4.2 BioTissue AG Business Overview
7.4.3 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.4.4 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.4.5 BioTissue AG Key News & Latest Developments
7.5 CartiHeal
7.5.1 CartiHeal Company Summary
7.5.2 CartiHeal Business Overview
7.5.3 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.5.4 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.5.5 CartiHeal Key News & Latest Developments
7.6 Geistlich Pharma AG
7.6.1 Geistlich Pharma AG Company Summary
7.6.2 Geistlich Pharma AG Business Overview
7.6.3 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.6.4 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.6.5 Geistlich Pharma AG Key News & Latest Developments
7.7 JRI Orthopaedics Ltd.
7.7.1 JRI Orthopaedics Ltd. Company Summary
7.7.2 JRI Orthopaedics Ltd. Business Overview
7.7.3 JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.7.4 JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.7.5 JRI Orthopaedics Ltd. Key News & Latest Developments
7.8 Matricel GmbH
7.8.1 Matricel GmbH Company Summary
7.8.2 Matricel GmbH Business Overview
7.8.3 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.8.4 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.8.5 Matricel GmbH Key News & Latest Developments
7.9 Smith & Nephew plc
7.9.1 Smith & Nephew plc Company Summary
7.9.2 Smith & Nephew plc Business Overview
7.9.3 Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.9.4 Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.9.5 Smith & Nephew plc Key News & Latest Developments
7.10 Zimmer Biomet Holdings
7.10.1 Zimmer Biomet Holdings Company Summary
7.10.2 Zimmer Biomet Holdings Business Overview
7.10.3 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Major Product Offerings
7.10.4 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global Market (2018-2023)
7.10.5 Zimmer Biomet Holdings Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Opportunities & Trends in Global Market
Table 2. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Drivers in Global Market
Table 3. Autologous Matrix-Induced Chondrogenesis (AMIC) Market Restraints in Global Market
Table 4. Key Players of Autologous Matrix-Induced Chondrogenesis (AMIC) in Global Market
Table 5. Top Autologous Matrix-Induced Chondrogenesis (AMIC) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Autologous Matrix-Induced Chondrogenesis (AMIC) Product Type
Table 9. List of Global Tier 1 Autologous Matrix-Induced Chondrogenesis (AMIC) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Matrix-Induced Chondrogenesis (AMIC) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2024-2030
Table 30. Anika Therapeutics, Inc. Company Summary
Table 31. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 32. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 33. Anika Therapeutics, Inc. Key News & Latest Developments
Table 34. Arthro-Kinetics Company Summary
Table 35. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 36. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 37. Arthro-Kinetics Key News & Latest Developments
Table 38. B. Braun Melsungen AG Company Summary
Table 39. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 40. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 41. B. Braun Melsungen AG Key News & Latest Developments
Table 42. BioTissue AG Company Summary
Table 43. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 44. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 45. BioTissue AG Key News & Latest Developments
Table 46. CartiHeal Company Summary
Table 47. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 48. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 49. CartiHeal Key News & Latest Developments
Table 50. Geistlich Pharma AG Company Summary
Table 51. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 52. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 53. Geistlich Pharma AG Key News & Latest Developments
Table 54. JRI Orthopaedics Ltd. Company Summary
Table 55. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 56. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 57. JRI Orthopaedics Ltd. Key News & Latest Developments
Table 58. Matricel GmbH Company Summary
Table 59. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 60. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 61. Matricel GmbH Key News & Latest Developments
Table 62. Smith & Nephew plc Company Summary
Table 63. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 64. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 65. Smith & Nephew plc Key News & Latest Developments
Table 66. Zimmer Biomet Holdings Company Summary
Table 67. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Product Offerings
Table 68. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue (US$, Mn) & (2018-2023)
Table 69. Zimmer Biomet Holdings Key News & Latest Developments
List of Figures
Figure 1. Autologous Matrix-Induced Chondrogenesis (AMIC) Segment by Type in 2022
Figure 2. Autologous Matrix-Induced Chondrogenesis (AMIC) Segment by Application in 2022
Figure 3. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue in 2022
Figure 8. By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 16. US Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 20. Germany Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 21. France Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 28. China Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 32. India Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 34. Brazil Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Market Share, 2018-2030
Figure 37. Turkey Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue, (US$, Mn), 2018-2030
Figure 41. Anika Therapeutics, Inc. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. B. Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. JRI Orthopaedics Ltd. Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Smith & Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
